Matrix Capital Management Company, LP
SEC insider (Form 3/4/5 filer). CIK 0001410830. 10% Owner at Aura Biosciences, Inc. (AURA) and 1 other issuer. 2 reported Form 4/5 transactions since Sep 2024; latest on May 7, 2026. Located in PORTSMOUTH, NH.
Companies Matrix Capital Management Company, LP has filed insider reports for
- Aura Biosciences, Inc. (AURA): 10% Owner
- Zentalis Pharmaceuticals, Inc. (ZNTL): 10% Owner
Matrix Capital Management Company, LP
CIK: 0001410830
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)2 (100.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
